The salvage role of allogeneic hematopoietic stem-cell transplantation in relapsed/refractory diffuse large B cell lymphoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
The salvage role of allogeneic hematopoietic stem-cell transplantation in relapsed/refractory diffuse large B cell lymphoma ; volume:13 ; number:1 ; day:15 ; month:10 ; year:2023 ; pages:1-11 ; date:12.2023
Scientific reports ; 13, Heft 1 (15.10.2023), 1-11, 12.2023
- Creator
-
Min, Gi-June
Jeon, Young-Woo
Kim, Tong Yoon
Kwag, Daehun
Kim, Byung-Su
Lee, Joonyeop
Lee, Jong Hyuk
Park, Sung-Soo
Park, Silvia
Yoon, Jae-Ho
Lee, Sung-Eun
Cho, Byung-Sik
Eom, Ki-Seong
Kim, Yoo-Jin
Lee, Seok
Kim, Hee-Je
Min, Chang-Ki
Lee, Jong Wook
Cho, Seok-Goo
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-023-44241-0
- URN
-
urn:nbn:de:101:1-2024020710413175488123
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:23 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Min, Gi-June
- Jeon, Young-Woo
- Kim, Tong Yoon
- Kwag, Daehun
- Kim, Byung-Su
- Lee, Joonyeop
- Lee, Jong Hyuk
- Park, Sung-Soo
- Park, Silvia
- Yoon, Jae-Ho
- Lee, Sung-Eun
- Cho, Byung-Sik
- Eom, Ki-Seong
- Kim, Yoo-Jin
- Lee, Seok
- Kim, Hee-Je
- Min, Chang-Ki
- Lee, Jong Wook
- Cho, Seok-Goo
- SpringerLink (Online service)
Other Objects (12)
Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia
Management of relapsed-refractory diffuse large B cell lymphoma
Activity of pembrolizumab in relapsed/refractory NK/T-cell lymphoma
BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma: a real-life experience
Consolidative allogeneic hematopoietic stem cell transplantation after chimeric antigen receptor T-cell therapy for relapsed/refractory B-cell acute lymphoblastic leukemia: who? When? Why?
Alemtuzumab-BEAM as conditioning for allogeneic hematopoietic stem cell transplantation in relapsed/refractory Hodgkin lymphoma: a single-center analysis
Phase I study of safety and efficacy of allogeneic natural killer cell therapy in relapsed/refractory neuroblastomas post autologous hematopoietic stem cell transplantation
Enhanced platelet function through CAR-T cell therapy in relapsed/refractory multiple myeloma
Single-cell transcriptomic and spatial analysis reveal the immunosuppressive microenvironment in relapsed/refractory angioimmunoblastic T-cell lymphoma
Secondary donor-derived humanized CD19-modified CAR-T cells induce remission in relapsed/refractory mixed phenotype acute leukemia after allogeneic hematopoietic stem cell transplantation: a case report
Treatment of Adult Patients with Relapsed/Refractory B-Cell Philadelphia-Negative Acute Lymphoblastic Leukemia
Novel clinical risk stratification and treatment strategies in relapsed/refractory peripheral T-cell lymphoma
Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia
Management of relapsed-refractory diffuse large B cell lymphoma
Activity of pembrolizumab in relapsed/refractory NK/T-cell lymphoma
BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma: a real-life experience
Consolidative allogeneic hematopoietic stem cell transplantation after chimeric antigen receptor T-cell therapy for relapsed/refractory B-cell acute lymphoblastic leukemia: who? When? Why?
Alemtuzumab-BEAM as conditioning for allogeneic hematopoietic stem cell transplantation in relapsed/refractory Hodgkin lymphoma: a single-center analysis
Phase I study of safety and efficacy of allogeneic natural killer cell therapy in relapsed/refractory neuroblastomas post autologous hematopoietic stem cell transplantation
Enhanced platelet function through CAR-T cell therapy in relapsed/refractory multiple myeloma
Single-cell transcriptomic and spatial analysis reveal the immunosuppressive microenvironment in relapsed/refractory angioimmunoblastic T-cell lymphoma
Secondary donor-derived humanized CD19-modified CAR-T cells induce remission in relapsed/refractory mixed phenotype acute leukemia after allogeneic hematopoietic stem cell transplantation: a case report
Treatment of Adult Patients with Relapsed/Refractory B-Cell Philadelphia-Negative Acute Lymphoblastic Leukemia
Novel clinical risk stratification and treatment strategies in relapsed/refractory peripheral T-cell lymphoma
Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia
Management of relapsed-refractory diffuse large B cell lymphoma
Activity of pembrolizumab in relapsed/refractory NK/T-cell lymphoma
BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma: a real-life experience
Consolidative allogeneic hematopoietic stem cell transplantation after chimeric antigen receptor T-cell therapy for relapsed/refractory B-cell acute lymphoblastic leukemia: who? When? Why?
Alemtuzumab-BEAM as conditioning for allogeneic hematopoietic stem cell transplantation in relapsed/refractory Hodgkin lymphoma: a single-center analysis
Phase I study of safety and efficacy of allogeneic natural killer cell therapy in relapsed/refractory neuroblastomas post autologous hematopoietic stem cell transplantation
Enhanced platelet function through CAR-T cell therapy in relapsed/refractory multiple myeloma
Single-cell transcriptomic and spatial analysis reveal the immunosuppressive microenvironment in relapsed/refractory angioimmunoblastic T-cell lymphoma
Secondary donor-derived humanized CD19-modified CAR-T cells induce remission in relapsed/refractory mixed phenotype acute leukemia after allogeneic hematopoietic stem cell transplantation: a case report
Treatment of Adult Patients with Relapsed/Refractory B-Cell Philadelphia-Negative Acute Lymphoblastic Leukemia